Whole Exome Sequencing Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables, Services), By Technology (Sequencing By Synthesis (ION Semiconductor Sequencing, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Others), By End-User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), by Country, Segment, and Companies, 2024-2032
The global Whole Exome Sequencing market size is poised to register 16.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Whole Exome Sequencing market across By Product (Instruments, Consumables, Services), By Technology (Sequencing By Synthesis (ION Semiconductor Sequencing, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Others), By End-User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
With the increasing demand for comprehensive genetic testing and precision medicine, there is a rising need for whole exome sequencing (WES) technologies to analyze the protein-coding regions of the genome and identify disease-causing variants and genetic predispositions. Market growth is driven by factors such as expanding research and clinical applications of genomics, the rising adoption of WES in rare disease diagnosis and cancer genomics, and technological advancements in sequencing platforms and bioinformatics tools. Additionally, the expanding availability of WES services in academic and clinical laboratories, as well as the growing interest in population genomics and genetic counseling, contribute to market expansion. Further, the development of scalable and cost-effective sequencing workflows, the integration of artificial intelligence and machine learning algorithms for variant interpretation, and the emphasis on data privacy and regulatory compliance are expected to further propel market growth in the coming years.
Whole Exome Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Whole Exome Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Whole Exome Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Whole Exome Sequencing industry.
Key market trends defining the global Whole Exome Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Whole Exome Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Whole Exome Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Whole Exome Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Whole Exome Sequencing industry
Leading Whole Exome Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Whole Exome Sequencing companies.
Whole Exome Sequencing Market Study- Strategic Analysis Review
The Whole Exome Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Whole Exome Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Whole Exome Sequencing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Whole Exome Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Whole Exome Sequencing market segments. Similarly, Strong market demand is encouraging Canadian Whole Exome Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Whole Exome Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Whole Exome Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Whole Exome Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Whole Exome Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Whole Exome Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Whole Exome Sequencing in Asia Pacific. In particular, China, India, and South East Asian Whole Exome Sequencing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Whole Exome Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Whole Exome Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Whole Exome Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Whole Exome Sequencing.
Whole Exome Sequencing Market Company Profiles
The global Whole Exome Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Azenta Life Sciences Inc, BGI Group, CD Genomics Inc, Eurofins Genomics Group, Illumina Inc, Novogene Co. Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc (PacBio), Thermo Fisher Scientific Inc.
Recent Whole Exome Sequencing Market Developments
The global Whole Exome Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Whole Exome Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Others
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By Application
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Others
By End-User
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Geographical Segmentation:
Agilent Technologies Inc
Azenta Life Sciences Inc
BGI Group
CD Genomics Inc
Eurofins Genomics Group
Illumina Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc (PacBio)
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
With the increasing demand for comprehensive genetic testing and precision medicine, there is a rising need for whole exome sequencing (WES) technologies to analyze the protein-coding regions of the genome and identify disease-causing variants and genetic predispositions. Market growth is driven by factors such as expanding research and clinical applications of genomics, the rising adoption of WES in rare disease diagnosis and cancer genomics, and technological advancements in sequencing platforms and bioinformatics tools. Additionally, the expanding availability of WES services in academic and clinical laboratories, as well as the growing interest in population genomics and genetic counseling, contribute to market expansion. Further, the development of scalable and cost-effective sequencing workflows, the integration of artificial intelligence and machine learning algorithms for variant interpretation, and the emphasis on data privacy and regulatory compliance are expected to further propel market growth in the coming years.
Whole Exome Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Whole Exome Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Whole Exome Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Whole Exome Sequencing industry.
Key market trends defining the global Whole Exome Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Whole Exome Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Whole Exome Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Whole Exome Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Whole Exome Sequencing industry
Leading Whole Exome Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Whole Exome Sequencing companies.
Whole Exome Sequencing Market Study- Strategic Analysis Review
The Whole Exome Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Whole Exome Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Whole Exome Sequencing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Whole Exome Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Whole Exome Sequencing market segments. Similarly, Strong market demand is encouraging Canadian Whole Exome Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Whole Exome Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Whole Exome Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Whole Exome Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Whole Exome Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Whole Exome Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Whole Exome Sequencing in Asia Pacific. In particular, China, India, and South East Asian Whole Exome Sequencing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Whole Exome Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Whole Exome Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Whole Exome Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Whole Exome Sequencing.
Whole Exome Sequencing Market Company Profiles
The global Whole Exome Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Azenta Life Sciences Inc, BGI Group, CD Genomics Inc, Eurofins Genomics Group, Illumina Inc, Novogene Co. Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc (PacBio), Thermo Fisher Scientific Inc.
Recent Whole Exome Sequencing Market Developments
The global Whole Exome Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Whole Exome Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Others
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By Application
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Others
By End-User
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agilent Technologies Inc
Azenta Life Sciences Inc
BGI Group
CD Genomics Inc
Eurofins Genomics Group
Illumina Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc (PacBio)
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Whole Exome Sequencing Market Overview and Key Findings, 2024
1.2 Whole Exome Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Whole Exome Sequencing Market Growth Opportunities to 2030
1.4 Key Whole Exome Sequencing Market Trends and Challenges
1.4.1 Whole Exome Sequencing Market Drivers and Trends
1.4.2 Whole Exome Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Whole Exome Sequencing Companies
2. WHOLE EXOME SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Whole Exome Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Whole Exome Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. WHOLE EXOME SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. WHOLE EXOME SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Others
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By Application
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Others
By End-User
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Whole Exome Sequencing Market, 2025
5.2 Asia Pacific Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Whole Exome Sequencing Market, 2025
5.5 Europe Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Whole Exome Sequencing Market, 2025
5.8 North America Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Whole Exome Sequencing Market, 2025
5.11 South America Pacific Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Whole Exome Sequencing Market, 2025
5.14 Middle East Africa Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Whole Exome Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Whole Exome Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Whole Exome Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Whole Exome Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Whole Exome Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Whole Exome Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Whole Exome Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Whole Exome Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Whole Exome Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Whole Exome Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Whole Exome Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Whole Exome Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Whole Exome Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Whole Exome Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Whole Exome Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Whole Exome Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Whole Exome Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Whole Exome Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Whole Exome Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Whole Exome Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Whole Exome Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Whole Exome Sequencing Industry Drivers and Opportunities
7. WHOLE EXOME SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. WHOLE EXOME SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Whole Exome Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Azenta Life Sciences Inc
BGI Group
CD Genomics Inc
Eurofins Genomics Group
Illumina Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc (PacBio)
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Whole Exome Sequencing Market Overview and Key Findings, 2024
1.2 Whole Exome Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Whole Exome Sequencing Market Growth Opportunities to 2030
1.4 Key Whole Exome Sequencing Market Trends and Challenges
1.4.1 Whole Exome Sequencing Market Drivers and Trends
1.4.2 Whole Exome Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Whole Exome Sequencing Companies
2. WHOLE EXOME SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Whole Exome Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Whole Exome Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. WHOLE EXOME SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. WHOLE EXOME SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Instruments
Consumables
Services
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Others
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By Application
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Others
By End-User
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Whole Exome Sequencing Market, 2025
5.2 Asia Pacific Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Whole Exome Sequencing Market, 2025
5.5 Europe Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Whole Exome Sequencing Market, 2025
5.8 North America Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Whole Exome Sequencing Market, 2025
5.11 South America Pacific Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Whole Exome Sequencing Market, 2025
5.14 Middle East Africa Whole Exome Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Whole Exome Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Whole Exome Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Whole Exome Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Whole Exome Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Whole Exome Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Whole Exome Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Whole Exome Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Whole Exome Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Whole Exome Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Whole Exome Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Whole Exome Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Whole Exome Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Whole Exome Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Whole Exome Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Whole Exome Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Whole Exome Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Whole Exome Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Whole Exome Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Whole Exome Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Whole Exome Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Whole Exome Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Whole Exome Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Whole Exome Sequencing Industry Drivers and Opportunities
7. WHOLE EXOME SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. WHOLE EXOME SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Whole Exome Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Azenta Life Sciences Inc
BGI Group
CD Genomics Inc
Eurofins Genomics Group
Illumina Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc (PacBio)
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
